Highly expressed IGF2BP3 can directly bind to the m6A-modified region of target mRNA, thereby promoting the stability and expression of specific genes, such as TMBIM6 [35], VEGF [36], and ABCB1 [37], leading to tumor progression, angiogenesis, and chemoresistance. This evidence concerns the gene IGF2BP3 and neoplasm.